Crystal size and properties of superparamagnetic iron oxide (SPIO) particles
- PMID: 9084026
- DOI: 10.1016/s0730-725x(96)00335-9
Crystal size and properties of superparamagnetic iron oxide (SPIO) particles
Abstract
The properties of a superparamagnetic iron oxide (SPIO) model contrast agent have been studied. The test material, HEP-SPIO, contained iron oxide multicrystal agglomerates coated with heparin, polyanionic, naturally occurring glycosaminoglycan. Fractionation of the HEP-SPIO suspension showed the existence of colloidally stable particles ranging from approx. 100 nm down to single crystal sizes. The small (< 20 nm) particles represented the major number fraction of particles present, but only approx. 2% of the total iron oxide mass. The volume weighted average diameter of the individual iron oxide crystals forming the multicrystal agglomerates was found to be 11-12 nm using transmission electron microscopy and vibrating sample magnetometry (VSM) techniques. Comparable results were obtained with X-ray diffraction and Mössbauer spectroscopy. A number of additional SPIO properties could also be determined on a routine VSM, such as the distribution standard deviation for the log-normal distribution of crystal sizes, the magnetic susceptibility, the magnetic remanence, and the intrinsic magnetization (magnetic moment) of the iron oxide. These parameters are useful tools for evaluation of the magnetic characteristics and contrast efficacy of SPIO contrast agents.
Similar articles
-
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.Magn Reson Imaging. 1995;13(5):661-74. doi: 10.1016/0730-725x(95)00024-b. Magn Reson Imaging. 1995. PMID: 8569441
-
[Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI].Bull Assoc Anat (Nancy). 1994 Mar;78(240):57-9. Bull Assoc Anat (Nancy). 1994. PMID: 7519906 French.
-
Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI.Magn Reson Med. 1992 Mar;24(1):75-84. doi: 10.1002/mrm.1910240108. Magn Reson Med. 1992. PMID: 1556931
-
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.Eur Radiol. 2001;11(11):2319-31. doi: 10.1007/s003300100908. Eur Radiol. 2001. PMID: 11702180 Review.
-
[Superparamagnetic iron oxide particles: current state and future development].Rofo. 2003 Jun;175(6):752-65. doi: 10.1055/s-2003-39935. Rofo. 2003. PMID: 12811686 Review. German.
Cited by
-
Advances in functional and molecular MRI technologies in chronic liver diseases.J Hepatol. 2020 Nov;73(5):1241-1254. doi: 10.1016/j.jhep.2020.06.020. Epub 2020 Jun 22. J Hepatol. 2020. PMID: 32585160 Free PMC article. Review.
-
Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets.Pharm Res. 2003 Dec;20(12):2001-7. doi: 10.1023/b:pham.0000008049.40370.5a. Pharm Res. 2003. PMID: 14725366 Clinical Trial.
-
Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine.Nanoscale Res Lett. 2012 Feb 21;7(1):144. doi: 10.1186/1556-276X-7-144. Nanoscale Res Lett. 2012. PMID: 22348683 Free PMC article.
-
'NC100150', a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography.MAGMA. 1999 Aug;8(3):207-13. doi: 10.1007/BF02594600. MAGMA. 1999. PMID: 10504049
-
Amphoteric β-cyclodextrin coated iron oxide magnetic nanoparticles: new insights into synthesis and application in MRI.Nanoscale Adv. 2024 Nov 4;7(1):155-168. doi: 10.1039/d4na00692e. eCollection 2024 Dec 17. Nanoscale Adv. 2024. PMID: 39569331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
